Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Occludin and Zonulin Levels in Attention-deficit/Hyperactivity Disorder

NCT05502471 is registered in ClinicalTrials.gov with Ataturk University as lead sponsor.

NCT NCT05502471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05502471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Occludin and Zonulin Levels in Attention-deficit/Hyperactivity Disorder
Lead sponsor
Ataturk University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2021
Completion date
June 1, 2021
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention-deficit/hyperactivity disorder